This clinical trial tests how well an educational brochure, with or without a behavioral nudge, works to increase colorectal cancer screening rates for eligible patients when given with a standard fecal immunochemical test (FIT) kit. Annual colorectal cancer screening with FIT is one of several recommended screening strategies that are noninvasive and can identify patients who may warrant further invasive screening. A behavioral nudge, consisting of a display of the sub-par screening rate of the patient's clinic compared to a collective New York State screening rate and a national screening rate goal, may encourage patients to complete screening. Adding a behavioral nudge to an educational brochure about FIT may increase screening completion rates compared to the educational brochure alone in eligible patients.
Additional locations may be listed on ClinicalTrials.gov for NCT06796049.
Locations matching your search criteria
United States
New York
New York
Laura and Isaac Perlmutter Cancer Center at NYU LangoneStatus: Approved
Contact: Aasma Shaukat
Phone: 212-263-3095
PRIMARY OBJECTIVE:
I. To determine if a behavioral nudge tactic can increase FIT screening completion rates among patients age 45-75 years old at Bellevue Outpatient Medicine Residents’ Clinic.
OUTLINE: Patients are assigned to 1 of 2 time periods.
TIME PERIOD 2: Patients receive an educational brochure, consisting of an easy-to-read description of FIT screening, instructions on how to complete the test, and the importance of FIT screening, alongside the standard of care FIT kit at the end of their clinic visit.
TIME PERIOD 3: Patients receive an educational brochure, consisting of an easy-to-read description of FIT screening, instructions on how to complete the test, and the importance of FIT screening as well as a behavioral nudge, alongside the standard of care FIT kit at the end of their clinic visit.
After completion of study intervention, patients are followed up for 3 months.
Trial PhaseNo phase specified
Trial Typescreening
Lead OrganizationLaura and Isaac Perlmutter Cancer Center at NYU Langone
Principal InvestigatorAasma Shaukat